Rhodococcus Equi and Arcanobacterium Haemolyticum: Two “Coryneform” Bacteria Increasingly Recognized As Agents of Human Infection

Total Page:16

File Type:pdf, Size:1020Kb

Rhodococcus Equi and Arcanobacterium Haemolyticum: Two “Coryneform” Bacteria Increasingly Recognized As Agents of Human Infection Synopses Rhodococcus equi and Arcanobacterium haemolyticum: Two “Coryneform” Bacteria Increasingly Recognized as Agents of Human Infection Regina Linder Hunter College, New York, New York, USA Rhodococcus equi and Arcanobacterium haemolyticum, formerly classified in the genus Corynebacterium, are members of the loosely defined taxon “coryneform” bac- teria. Although they are the etiologic agents of distinct human infections, both organisms are frequently overlooked, which results in missed or delayed diagnoses. R. equi, long known as an important pathogen of immature horses, has become in the past three decades an opportunistic pathogen of severely immunosuppressed humans. Most cases are secondary to HIV infection. When specifically sought in throat swab cultures, A. haemolyticum is found responsible for 0.5% to 2.5% of bacterial pharyngitis, especially among adolescents. These two microorganisms represent a spectrum of disease in humans: from a mild, common illness to a rare life-threatening infection. Each organism elaborates lipid hydrolyzing enzymes (cholesterol oxidase by R. equi and sphingomyelinase D by A. haemolyticum) that are toxic to animals and humans and damaging to mammalian cell membranes. The participation of the cytotoxins in pathogenicity is discussed. Greater awareness of the properties of these two bacteria may promote faster, more accurate diagnoses and better clinical management. A variety of factors contribute to the under- human pathogens, rigorous biochemical and reporting of human infections caused by bacteria molecular tools have increasingly been applied to in the genus Corynebacterium and closely related isolates. The resulting improved epidemiology genera. The group, often referred to as “coryne- and taxonomy have led, for example, to the defi- form,” comprises taxonomically diverse gram- nition of CDC groups JK and D-2 in the genus positive rods resembling Corynebacterium diph- Corynebacterium, now recognized as important theriae and displaying pleomorphism and irregu- opportunistic pathogens (1). Similarly, more accu- lar cellular arrangements (1,2). The group rate characterization of some species caused includes human and animal pathogens, as well as them to be removed from the genus Corynebac- commensal bacteria. The control of diphtheria in terium. Excellent reviews of the pathogenicity industrialized countries and the subsequent and epidemiology of these diverse genera have deemphasis of the genus Corynebacterium have been published (1,2). This article explores two contributed to discounting isolates characteristic pathogenic coryneform bacteria: Rhodococcus equi, of the genus as contaminants. Even reference a rare often fatal human pathogen, in which laboratories report difficulty in the speciation of virtually all human infections occur among com- gram-positive pleomorphic rods that resemble promised hosts; and Arcanobacterium haemo- corynebacteria (1). Because of the emergence of a lyticum, which is responsible for many respiratory number of coryneform bacteria as important infections in healthy people. This article aims to bring about improved recognition of these two easily overlooked pathogens and considers mecha- Address for correspondence: Regina Linder, School of Health Sciences, Hunter College, 425 East 25th St., New York, NY 10010, nisms underlying the diseases, the immune USA; fax: 212-420-9135; e-mail: [email protected]. response of the hosts, and treatment protocols. Vol. 3, No. 2, April–June 1997 145 Emerging Infectious Diseases Synopses Epidemiology and Clinical Presentation with antimicrobial agents than cases in AIDS patients (8). Most often, patients have a slowly R. equi progressive granulomatous pneumonia, with Originally isolated by Magnusson in 1923 lobar infiltrates, frequently developing to cavitating from granulomatous lung infections in young lesions visible on chest x-ray. Other sites of horses (3), Corynebacterium (now Rhodococcus infection include abscesses of the central nervous equi) remains an important pathogen of foals. system, pelvis, and subcutaneous tissue, and Much of the considerable body of knowledge about lymphadenitis (7,8-10). Cases of lung infection R. equi, including its pathogenicity and immune caused by inhalation and cutaneous lesions caused response to infection, derives from veterinary by wound contamination have been documented; studies and has been recently updated (4). the latter are almost the only R. equi infections R. equi is readily found in soil, especially reported in healthy persons, frequently children where domesticated livestock graze (5). The stool (11). Delays in accurate diagnosis of R. equi are of horses and other animals is the source of soil still common (2,7), despite increased awareness contamination. Infection in humans derives from of this organism as an opportunistic pathogen in environmental exposure (2,5), and the organism humans. Factors for delayed diagnosis include may be ubiquitous in soil (6). While early cases the insidious onset of disease, clinical resemblance occurred mostly in persons with a history of of the infection to mycobacterial, fungal, and contact with horses, only 20% to 30% of recent actinomycotic infections, and the relatively non- cases can be traced to such contact (7). A review of descript bacteriologic profile of R. equi. Morphology, cases in the three decades since the first reported partial acid fastness, and a distinctive histo- human infection in 1967 is presented in Table 1. pathologic profile in bronchial specimens (Figure 1 R. equi is a rare opportunistic pathogen found A and B) contribute to accurate diagnosis. in severely compromised patients, and most com- Numerous polymorphonuclear leukocytes with monly in recent years, in human immunodefi- intracellular pleomorphic gram-positive bacteria, ciency virus (HIV)-infected persons. Early cases, microabscesses, pseudotumors, and malakoplakia most in patients receiving immunosuppressant are noted on tissue (7,11). Malakoplakia is a therapy, were more likely to be successfully treated relatively rare granulomatous inflammation not Table 1. Rhodococcus equi case reports in humans: 1967–1996 Primary site Predisposing condition of infection Years Cases (number) (number) Deaths Referencesa 1967–76 7 Corticosteroid (1) Lung (6) 0 8–10 Cancer/immunosuppressant (3) Lymphatic (1) Renal transplant (2) Noneb (1) 1977–86 15 Corticosteroid (1) Lung (14) 8 8–10,22 Cancer/immunosuppressant (4) Blood (1) Renal transplant (2) HIV (7) Alcoholism (1) 1987–96 93 Cancer/immunosuppressant (8) Lung (72) 34 8–13,22 Renal transplant (3) Lymphatic (2) HIV (67) Blood (8) Otherc (8) (1b) Wound (6) None (7) (4b) Otherd (5) aIn the interest of space, case compilations are cited in lieu of individual case reports. bChild cIncludes intravenous drug use, lab infection, emphysema, kidney disease. dCentral nervous system, gastrointestinal Emerging Infectious Diseases 146 Vol. 3, No. 2, April–June 1997 Synopses A Corynebacterium haemolyticum A. haemolyticum was first described and named by MacClean et al. (14), who isolated it from pharyngeal infections in U.S. soldiers and natives in the South Pacific. Classification of the organism generated controversy until the defini- tion in 1982 of a new genus, Arcanobacterium (secretive bacterium), in which it remains the only species (15). Unlike R. equi infection, where invasive clini- cal disease underscores the need to detect and identify the causative agent of infection, A. haemo- lyticum infection is often reported from deliberate screening for the organism of a large number of patients with sore throats. After it was identified B during World War II from patients with pharyn- gitis (14), it was occasionally reported from Europe, the United States, and in 1981, Sri Lanka (16 cases) (16). Most cases involve pharyngitis and/or tonsillitis, and approximately 50% are exudative. Throat infections are often accompanied by cervi- cal lymphadenopathy (17,18). Diagnosis of cases (distinct from screening studies) often occurs only after recurrent infections, which are thought to be related to incorrect initial diagnosis, resulting in less-than-optimum treatment (19). Infection is most common in 15- to 25-year-old persons, and is Figure 1. A. Bronchial tissue Gram stain showing thought to result from droplet transfer from intrahistiocytic coccobacillary forms of Rhodococcus infected persons (20). Symptoms resemble those equi. Original magnification, x 1,000. B. Open lung of ß-hemolytic streptococci or viral infection. The biopsy showing coalescent microabscesses with spectrum of disease ranges from sore throat to, in numerous histiocytes containing Rhodococcus equi rare cases, a life-threatening membranous pharyn- organisms. PAS stain. Original magnification x 250. gitis resembling diphtheria (18,20). An erythe- Figure provided by Dr. Margie Scott, Vanderbilt matous morbilliform or scarlatinal rash of the University Medical Center. trunk, neck, or extremities is associated with 20% to 25% of cases (19), enhancing the possibility of misdiagnosis as streptococcal infection or penicillin typically associated with histology of lung infec- allergy, because ß-lactam therapy is frequently tion and can be of help in forming a differential initiated without accurate diagnosis. A recent diagnosis (11,12). Firm diagnosis and differen- report des-cribes in detail the dermatologic tiation from similar pathogens require the isola- manifestations of A. haemolyticum infection (20). tion and identification of R. equi from sputum, The
Recommended publications
  • ID 2 | Issue No: 4.1 | Issue Date: 29.10.14 | Page: 1 of 24 © Crown Copyright 2014 Identification of Corynebacterium Species
    UK Standards for Microbiology Investigations Identification of Corynebacterium species Issued by the Standards Unit, Microbiology Services, PHE Bacteriology – Identification | ID 2 | Issue no: 4.1 | Issue date: 29.10.14 | Page: 1 of 24 © Crown copyright 2014 Identification of Corynebacterium species Acknowledgments UK Standards for Microbiology Investigations (SMIs) are developed under the auspices of Public Health England (PHE) working in partnership with the National Health Service (NHS), Public Health Wales and with the professional organisations whose logos are displayed below and listed on the website https://www.gov.uk/uk- standards-for-microbiology-investigations-smi-quality-and-consistency-in-clinical- laboratories. SMIs are developed, reviewed and revised by various working groups which are overseen by a steering committee (see https://www.gov.uk/government/groups/standards-for-microbiology-investigations- steering-committee). The contributions of many individuals in clinical, specialist and reference laboratories who have provided information and comments during the development of this document are acknowledged. We are grateful to the Medical Editors for editing the medical content. For further information please contact us at: Standards Unit Microbiology Services Public Health England 61 Colindale Avenue London NW9 5EQ E-mail: [email protected] Website: https://www.gov.uk/uk-standards-for-microbiology-investigations-smi-quality- and-consistency-in-clinical-laboratories UK Standards for Microbiology Investigations are produced in association with: Logos correct at time of publishing. Bacteriology – Identification | ID 2 | Issue no: 4.1 | Issue date: 29.10.14 | Page: 2 of 24 UK Standards for Microbiology Investigations | Issued by the Standards Unit, Public Health England Identification of Corynebacterium species Contents ACKNOWLEDGMENTS .........................................................................................................
    [Show full text]
  • Responses to Ecopollutants and Pathogenization Risks of Saprotrophic Rhodococcus Species
    pathogens Review Responses to Ecopollutants and Pathogenization Risks of Saprotrophic Rhodococcus Species Irina B. Ivshina 1,2,*, Maria S. Kuyukina 1,2 , Anastasiia V. Krivoruchko 1,2 and Elena A. Tyumina 1,2 1 Perm Federal Research Center UB RAS, Institute of Ecology and Genetics of Microorganisms UB RAS, 13 Golev Str., 614081 Perm, Russia; [email protected] (M.S.K.); [email protected] (A.V.K.); [email protected] (E.A.T.) 2 Department of Microbiology and Immunology, Perm State University, 15 Bukirev Str., 614990 Perm, Russia * Correspondence: [email protected]; Tel.: +7-342-280-8114 Abstract: Under conditions of increasing environmental pollution, true saprophytes are capable of changing their survival strategies and demonstrating certain pathogenicity factors. Actinobacteria of the genus Rhodococcus, typical soil and aquatic biotope inhabitants, are characterized by high ecological plasticity and a wide range of oxidized organic substrates, including hydrocarbons and their derivatives. Their cell adaptations, such as the ability of adhering and colonizing surfaces, a complex life cycle, formation of resting cells and capsule-like structures, diauxotrophy, and a rigid cell wall, developed against the negative effects of anthropogenic pollutants are discussed and the risks of possible pathogenization of free-living saprotrophic Rhodococcus species are proposed. Due to universal adaptation features, Rhodococcus species are among the candidates, if further anthropogenic pressure increases, to move into the group of potentially pathogenic organisms with “unprofessional” parasitism, and to join an expanding list of infectious agents as facultative or occasional parasites. Citation: Ivshina, I.B.; Kuyukina, Keywords: actinobacteria; Rhodococcus; pathogenicity factors; adhesion; autoaggregation; colonization; M.S.; Krivoruchko, A.V.; Tyumina, defense against phagocytosis; adaptive strategies E.A.
    [Show full text]
  • Kansas Journal of Medicine, Volume 11 Issue 1
    VOLUME 11 • ISSUE 1 • Feb. 2018 WHAT’S INSIDE: ORIGINAL RESEARCH • CASE STUDIES • REVIEW TABLE OF CONTENTS ORIGINAL RESEARCH 1 Safe Sleep Practices of Kansas Birthing Hospitals Carolyn R. Ahlers-Schmidt, Ph.D., Christy Schunn, LSCSW, Cherie Sage, M.S., Matthew Engel, MPH, Mary Benton, Ph.D. CASE STUDIES 5 Neck Trauma and Extra-tracheal Intubation Vinh K. Pham, M.D., Justin C. Sandall, D.O. 8 Strongyloides Duodenitis in an Immunosuppressed Patient with Lupus Nephritis Ramprasad Jegadeesan, M.D., Tharani Sundararajan, MBBS, Roshni Jain, MS-3, Tejashree Karnik, M.D., Zalina Ardasenov, M.D., Elena Sidorenko, M.D. 11 Arcanobacterium Brain Abscesses, Subdural Empyema, and Bacteremia Complicating Epstein-Barr Virus Mononucleosis Victoria Poplin, M.D., David S. McKinsey, M.D. REVIEW 15 Transgender Competent Provider: Identifying Transgender Health Needs, Health Disparities, and Health Coverage Sarah Houssayni, M.D., Kari Nilsen, Ph.D. 20 The Increased Vulnerability of Refugee Population to Mental Health Disorders Sameena Hameed, Asad Sadiq, MBChB, MRCPsych, Amad U. Din, M.D., MPH KANSAS JOURNAL of MEDICINE deaths attributed to SIDS had one or more factors contributing to an unsafe sleep environment.3 The American Academy of Pediatrics (AAP) recommendations for a safe infant sleeping environment delineate a number of modifi- able factors to reduce the risk of sleep-related infant deaths.4 Factors Safe Sleep Practices of Kansas Birthing include back sleep only, room-sharing without bed-sharing, use of a Hospitals firm sleep surface, keeping soft bedding and other items out of the Carolyn R. Ahlers-Schmidt, Ph.D.1, Christy Schunn, LSCSW2, crib, and avoiding infant overheating.
    [Show full text]
  • (Publication Only) Corynebacterium Spp. and Arcanobacterium Haemolyticum Identification
    R2737 Abstract (publication only) Corynebacterium spp. and Arcanobacterium haemolyticum identification. Usefulness of the Vitek 2 ANC card R. Soloaga*, N. Carrion, C. Barberis, M. Almuzara, L. Guelfand, J. Pidone, C. Vay (Buenos Aires, AR) Introduction: Corynebacterium diphtheriae and C.ulcerans may be isolated from suspected cases of classical diphtheria, cutaneous diphtheria and very rarely from other clinical infections. Non-diphtheric corynebacteria are opportunistic pathogens, especially in nosocomial setting where they have been associated with endocarditis, pulmonary infection, medical devices infections and urinary tract infection. A. haemolyticum infection manifests as exudative pharyngitis and tonsillitis accompanied by cervical lymphadenopathy and less commonly, the organism causes deep-seated infections and skin and soft-tissue infections Objective: The aim of this study was to determine the Vitek 2 ANC card (bioMèrieux, Marcy l’Etoile, France) performance for identification of the most frequently clinical relevant Corynebacterium species and Arcanobacterium haemolyticum Methods: Sixty-two unique clinical isolates (2 C. diphtheriae, 7 C. jeikeium, 10 C. amycolatum, 15 C.striatum, 12 C.urealyticum, 1 C.minutissimum, 8 C. pseudodiphtheriticum, 1 C. ulcerans and 6 Arcanobacterium haemolyticum) represented the 9 taxa included in the Vitek 2 ANC database and 6 strains represented related species not included in the database were analyzed in this study. All the strains were identified using 16S rRNA gene sequencing (16S) as the reference method. For Vitek identification, all the strains were isolated in pure culture on Columbia blood agar. After 24-48 h incubation to 35ºC in ambient air, a bacterial suspension was made in 0.45% aqueous ClNa and adjusted to a McFarland of 2.7-3.2 with Vitekk 2 Densicheck instrument (bioMérieux).The inoculated card was loaded into the Vitek 2C automated identification system according to the manufacturer´s instruction.
    [Show full text]
  • Arcanobacterium Haemolyticum Type Strain (11018)
    Lawrence Berkeley National Laboratory Recent Work Title Complete genome sequence of Arcanobacterium haemolyticum type strain (11018). Permalink https://escholarship.org/uc/item/03f632gf Journal Standards in genomic sciences, 3(2) ISSN 1944-3277 Authors Yasawong, Montri Teshima, Hazuki Lapidus, Alla et al. Publication Date 2010-09-28 DOI 10.4056/sigs.1123072 Peer reviewed eScholarship.org Powered by the California Digital Library University of California Standards in Genomic Sciences (2010) 3:126-135 DOI:10.4056/sigs.1123072 Complete genome sequence of Arcanobacterium T haemolyticum type strain (11018 ) Montri Yasawong1, Hazuki Teshima2,3, Alla Lapidus2, Matt Nolan2, Susan Lucas2, Tijana Glavina Del Rio2, Hope Tice2, Jan-Fang Cheng2, David Bruce2,3, Chris Detter2,3, Roxanne Tapia2,3, Cliff Han2,3, Lynne Goodwin2,3, Sam Pitluck2, Konstantinos Liolios2, Natalia Ivanova2, Konstantinos Mavromatis2, Natalia Mikhailova2, Amrita Pati2, Amy Chen4, Krishna Palaniappan4, Miriam Land2,5, Loren Hauser2,5, Yun-Juan Chang2,5, Cynthia D. Jeffries2,5, Manfred Rohde1, Johannes Sikorski6, Rüdiger Pukall6, Markus Göker6, Tanja Woyke2, James Bristow2, Jonathan A. Eisen2,7, Victor Markowitz4, Philip Hugenholtz2, Nikos C. Kyrpides2, and Hans-Peter Klenk6* 1 HZI – Helmholtz Centre for Infection Research, Braunschweig, Germany 2 DOE Joint Genome Institute, Walnut Creek, California, USA 3 Los Alamos National Laboratory, Bioscience Division, Los Alamos, New Mexico, USA 4 Biological Data Management and Technology Center, Lawrence Berkeley National Laboratory, Berkeley, California, USA 5 Oak Ridge National Laboratory, Oak Ridge, Tennessee, USA 6 DSMZ - German Collection of Microorganisms and Cell Cultures GmbH, Braunschweig, Germany 7 University of California Davis Genome Center, Davis, California, USA *Corresponding author: Hans-Peter Klenk Keywords: obligate parasite, human pathogen, pharyngeal lesions, skin lesions, facultative anaerobe, Actinomycetaceae, Actinobacteria, GEBA Arcanobacterium haemolyticum (ex MacLean et al.
    [Show full text]
  • Evaluation Ofapi Coryne System for Identifying Coryneform Bacteria
    756 Y Clin Pathol 1994;47:756-759 Evaluation of API Coryne system for identifying coryneform bacteria J Clin Pathol: first published as 10.1136/jcp.47.8.756 on 1 August 1994. Downloaded from A Soto, J Zapardiel, F Soriano Abstract that are aerobe or facultatively aerobe, non- Aim-To identify rapidly and accurately spore forming organisms of the following gen- coryneform bacteria, using a commercial era: Corynebacterium, Listeria, Actinomyces, strip system. Arcanobacterium, Erysipelothrix, Oerskovia, Methods-Ninety eight strains of Cory- Brevibacterium and Rhodococcus. It also per- nebacterium species and 62 additional mits the identification of Gardnerella vaginalis strains belonging to genera Erysipelorix, which often has a diphtheroid appearance and Oerskovia, Rhodococcus, Actinomyces, a variable Gram stain. Archanobacterium, Gardnerella and We studied 160 organisms in total from dif- Listeria were studied. Bacteria were ferent species of the Corynebacterium genus, as identified using conventional biochemi- well as from other morphological related gen- cal tests and a commercial system (API- era or groups, some of them not included in Coryne, BioMerieux, France). Fresh rab- the API Coryne database. bit serum was added to fermentation tubes for Gardnerella vaginalis isolates. Results-One hundred and five out ofthe Methods 160 (65.7%) organisms studied were cor- The study was carried out on Gram positive rectly and completely identified by the bacilli belonging to the genera Coryne- API Coryne system. Thirty five (21.8%) bacterium, Erysipelothrix, Oerskovia, Rhodococcus, more were correctly identified with addi- Actinomyces, Arcanobacterium, Gardnerella and tional tests. Seventeen (10-6%) organisms Listeria included in the API Coryne database were not identified by the system and (table 1).
    [Show full text]
  • Validation in Horse Foals Challenged with the TB-Related
    bioRxiv preprint doi: https://doi.org/10.1101/292946; this version posted April 2, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Antibody-based vaccine for tuberculosis: validation in horse foals challenged 2 with the TB-related pathogen Rhodococcus equi 3 4 C. Cywes-Bentley1†, J. N. Rocha2†, A. I. Bordin2, M. Vinacur1, S. Rehman1, T.S. 5 Zaidi1, M. Meyer3, S. Anthony3, M. Lambert3, D. R. Vlock4, S. Giguère5, N. D. 6 Cohen2*, G. B. Pier1* 7 8 Affiliations: 9 1 Harvard Medical School, Brigham & Women’s Hospital, Boston, MA, USA. 10 2College of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College 11 Station, TX, USA. 12 3Mg Biologics, Ames, IA, USA 13 3ALOPEXX Vaccine LLC, Concord, MA, USA. 14 4College of Veterinary Medicine, University of Georgia, Athens, GA, USA 15 † Co-first authors 16 *To whom correspondence should be addressed: Drs. Cohen and Pier serve jointly as 17 corresponding authors: [email protected] and [email protected] 18 bioRxiv preprint doi: https://doi.org/10.1101/292946; this version posted April 2, 2018. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 19 Abstract: 20 Immune correlates for protection against Mycobacterium tuberculosis (Mtb) infection 21 and other intracellular pathogens are largely undetermined. Whether there is a role for 22 antibody-mediated immunity is controversial. Rhodococcus equi is an intracellular 23 pathogen causing severe pneumonia in young horse foals, eliciting a disease with many 24 similarities to TB including intracellular residence, formation of granulomas and 25 induction of severe respiratory distress.
    [Show full text]
  • The Rhodococcus Equi Virulence Protein Vapa Disrupts Endolysosome Function and Stimulates Lysosome Biogenesis
    This is a repository copy of The Rhodococcus equi virulence protein VapA disrupts endolysosome function and stimulates lysosome biogenesis. White Rose Research Online URL for this paper: https://eprints.whiterose.ac.uk/104956/ Version: Accepted Version Article: Rofe, Adam P, Davis, Luther J, Whittingham, Jean L et al. (3 more authors) (2016) The Rhodococcus equi virulence protein VapA disrupts endolysosome function and stimulates lysosome biogenesis. Microbiology Open. e00416. ISSN 2045-8827 https://doi.org/10.1002/mbo3.416 Reuse This article is distributed under the terms of the Creative Commons Attribution (CC BY) licence. This licence allows you to distribute, remix, tweak, and build upon the work, even commercially, as long as you credit the authors for the original work. More information and the full terms of the licence here: https://creativecommons.org/licenses/ Takedown If you consider content in White Rose Research Online to be in breach of UK law, please notify us by emailing [email protected] including the URL of the record and the reason for the withdrawal request. [email protected] https://eprints.whiterose.ac.uk/ The Rhodococcus equi virulence protein VapA disrupts endolysosome function and stimulates lysosome biogenesis. Adam P. Rofe1, Luther J. Davis2, Jean L. Whittingham3, Elizabeth C. Latimer- Bowman2, Anthony J. Wilkinson3 and Paul R. Pryor1,4* 1 Department of Biology, Wentworth Way, University of York, York. YO10 5DD. United Kingdom; 2 Cambridge Institute for Medical Research and Department of Clinical Biochemistry, University of Cambridge, Addenbrooke’s Hospital, Hills Rd, Cambridge, CB2 0XY; 3 Structural Biology Laboratory, Department of Chemistry, University of York York.
    [Show full text]
  • Rhodococcus Equi
    DISPATCHES apy consisting of cyclophosphamide, doxorubicin, vincris- Rhodococcus equi tine, and prednisolone every 2 weeks (CHOP14), in com- bination with alemtuzumab 30 mg subcutaneously on days Infection after 1, 5, and 9 of each cycle. This combined therapy was well tolerated. Complete cytologic and immunohistochemical Alemtuzumab remission was confi rmed by blood and bone marrow ex- amination 2 weeks after the latest chemotherapy treatment. Therapy for T-cell Ten weeks later, the patient experienced fl u-like symptoms Prolymphocytic and had a fever of 38.9°C. One week earlier, the antimicro- bial prophylaxis, which consisted of valacyclovir, 500 mg Leukemia 2 times/day, and trimethoprim-sulfamethoxazole, 960 mg 3 times/week, had been stopped, although the alemtuzumab- Jan J. Meeuse,* Herman G. Sprenger,* induced lymphocytopenia was still present (leukocytes 7.2 Sander van Assen,* Dominique Leduc,† × 109/L, 84% neutrophils, 0.6% lymphocytes). Outpatient Simon M.G.J. Daenen,* Jan P. Arends,* evaluation showed 2 lung abscesses. From 3 consecutive and Tjip S. van der Werf* blood cultures and from the bronchoalveolar lavage fl uid, Rhodococcus equi, mainly known from veterinary med- a gram-positive bacillus with mucoid growth was isolated icine as a pathogen in domestic animals, can also cause and identifi ed as R. equi (API Coryne, bioMérieux, Marcy infections in immunocompromised humans, especially in l’Etoile, France). The isolated strain was resistant to β-lac- those with defects in cellular immunity. Alemtuzumab, an tam antimicrobial drugs and trimethoprim-sulfamethoxa- anti-CD52 monoclonal antibody, causes lymphocytopenia zole and susceptible to aminoglycosides, tetracyclines, fl u- by eliminating CD52-positive cells.
    [Show full text]
  • Diversity and Prevalence of ANTAR Rnas Across Actinobacteria
    bioRxiv preprint doi: https://doi.org/10.1101/2020.10.11.335034; this version posted October 11, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. Diversity and prevalence of ANTAR RNAs across actinobacteria Dolly Mehta1,2 and Arati Ramesh1,+ 1National Centre for Biological Sciences, Tata Institute of Fundamental Research, GKVK Campus, Bellary Road, Bangalore, India 560065. 2SASTRA University, Tirumalaisamudram, Thanjavur – 613401. +Corresponding Author: Arati Ramesh National Centre for Biological Sciences GKVK Campus, Bellary Road Bangalore, 560065 Tel. 91-80-23666930 e-mail: [email protected] Running title: Identification of ANTAR RNAs across Actinobacteria Keywords: ANTAR protein:RNA regulatory system, structured RNA, actinobacteria 1 bioRxiv preprint doi: https://doi.org/10.1101/2020.10.11.335034; this version posted October 11, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC-ND 4.0 International license. ABSTRACT Computational approaches are often used to predict regulatory RNAs in bacteria, but their success is limited to RNAs that are highly conserved across phyla, in sequence and structure. The ANTAR regulatory system consists of a family of RNAs (the ANTAR-target RNAs) that selectively recruit ANTAR proteins. This protein-RNA complex together regulates genes at the level of translation or transcriptional elongation.
    [Show full text]
  • Rhodococcus and Mycobacterium Tuberculosis: Masquerade Or Mixed Infection
    INT J TUBERC LUNG DIS 10(3):351–353 CASE STUDY © 2006 The Union Rhodococcus and Mycobacterium tuberculosis: masquerade or mixed infection N. F. Mistry,* Y. Dholakia,* D. T. B. D’Souza,* M. Taylor,† S. Hoffner,‡ T. J. Birdi* * Foundation for Medical Research, Mumbai, India; † Imperial College School of Science, Technology and Medicine, London, United Kingdom; ‡ Swedish Institute for Infectious Disease Control, Stockholm, Sweden SUMMARY Rhodocci have a morphology similar to that of Myco- emergence of resistance. We present here a sputum smear bacterium tuberculosis (TB), and are indistinguishable AFB-positive case who, although clinically cured, re- from normal diphtheroid flora. Symptoms include fever, mains unresolved despite a series of technological inves- productive/non-productive cough and pleuritic chest tigations as to the cause of infection being purely rhodo- pain. Rhodococcal infections, being resistant to routine cocci or mixed infection with M. tuberculosis. anti-tuberculosis medications, may be misdiagnosed as KEY WORDS: Mycobacterium tuberculosis; Rhodococ- drug-resistant TB, thus prompting treatment for TB cus equi; rpo␤ mutations; mixed infections; IS1081; Oxy R with rifampicin-containing regimens that promote the ALTHOUGH they are resistant to routine anti- attacks and the smear results, anti-tuberculosis treat- tuberculosis treatment, rhodococci are morphologi- ment (HRZE*) was commenced on 18 May 2002 cally similar to Mycobacterium tuberculosis (TB), along with haematinics and ayurvedic immune mod- and are indistinguishable from normal diphtheroid ulators. The latter were temporarily withheld follow- respiratory flora.1,2 Symptoms include fever, productive/ ing a bout of acute bronchospasm. The paroxysmal non-productive cough and pleuritic chest pain. Rhodo- cough episodes persisted up to 9 weeks with fluctua- Q: “Although the” What word is missing? Q: “Although the” What word coccal infections, being resistant to routine anti- tions in respiratory symptoms.
    [Show full text]
  • Primary Retroperitoneal Abscesses Due to Rhodococcus Equi in a Patient with Severe Nephrotic Syndrome: Successful Antibiotic Treatment with Linezolid and Tigecycline
    International Journal of Infectious Diseases 14 (2010) e533–e535 Contents lists available at ScienceDirect International Journal of Infectious Diseases journal homepage: www.elsevier.com/locate/ijid Case Report Primary retroperitoneal abscesses due to Rhodococcus equi in a patient with severe nephrotic syndrome: successful antibiotic treatment with linezolid and tigecycline Gianluca Russo *, Miriam Lichtner, Martina Carnevalini, Maria Teresa Mascellino, Fabio Mengoni, Alessandra Oliva, Ginevra Azzurra Miccoli, Marco Iannetta, Vito Trinchieri, Anna Paola Massetti, Claudio Maria Mastroianni, Vincenzo Vullo Department of Tropical and Infectious Diseases, ‘‘Sapienza’’ University of Rome, Viale del Policlinico 155, 00161, Rome, Italy ARTICLE INFO ABSTRACT Article history: We present a case of Rhodococcus equi primary retroperitoneal abscesses without pulmonary Received 19 January 2009 involvement in an immunocompromised patient with severe nephrotic syndrome. No risk factors for Received in revised form 10 June 2009 exposure to R. equi were present. The infection was successfully treated with long-term combination Accepted 15 June 2009 antibiotic treatment including linezolid and tigecycline. Corresponding Editor: Timothy Barkham, ß 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved. Tan Tock Seng, Singapore Keywords: Rhodococcus Retroperitoneal abscess Nephrotic syndrome Linezolid Tigecycline 1. Introduction genous dissemination, in an immunocompromised patient with severe nephrotic syndrome.
    [Show full text]